These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 8685038

  • 21. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M, Leonardi E, Mauri FA, Serio G, Dalla Palma P.
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [Abstract] [Full Text] [Related]

  • 22. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 23. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity.
    Bhargava V, Kell DL, van de Rijn M, Warnke RA.
    Am J Pathol; 1994 Sep; 145(3):535-40. PubMed ID: 8080038
    [Abstract] [Full Text] [Related]

  • 24. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S.
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [Abstract] [Full Text] [Related]

  • 25. [Prognosis prediction of S-phase fraction and p53, c-erbB-2, estrogen receptor, progesterone receptor in axillary node-negative breast cancer].
    Zhang S, Yuan Y, Wang X.
    Zhonghua Wai Ke Za Zhi; 1997 Aug; 35(8):475-7. PubMed ID: 10678068
    [Abstract] [Full Text] [Related]

  • 26. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
    Tawfik K, Kimler BF, Davis MK, Fan F, Tawfik O.
    Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
    [Abstract] [Full Text] [Related]

  • 27. Tissue microarray analysis of FAS, Bcl-2, Bcl-x, ER, PgR, Hsp60, p53 and Her2-neu in breast carcinoma.
    Sebastiani V, Botti C, Di Tondo U, Visca P, Pizzuti L, Santeusanio G, Alo PL.
    Anticancer Res; 2006 Jan; 26(4B):2983-7. PubMed ID: 16886624
    [Abstract] [Full Text] [Related]

  • 28. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH, Dervan PA, O'Regan M, Codd MB, Gullick WJ, Tobin BM, Carney DN.
    Cancer Res; 1991 Jun 15; 51(12):3296-303. PubMed ID: 1674898
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of oestrogen and progesterone receptors, and c-erbB-2 in carcinoma of the breast in Trinidadian women.
    Rao AV, Mohammed WA, Ragoonanan C, Omo-Igbinomwanhia NE.
    West Indian Med J; 2002 Mar 15; 51(1):4-9. PubMed ID: 12089875
    [Abstract] [Full Text] [Related]

  • 30. Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer.
    Horita K, Yamaguchi A, Hirose K, Ishida M, Noriki S, Imamura Y, Fukuda M.
    Eur J Histochem; 2001 Mar 15; 45(1):73-84. PubMed ID: 11411868
    [Abstract] [Full Text] [Related]

  • 31. The presence of serum anti-p53 antibodies from patients with invasive ductal carcinoma of breast: correlation to other clinical and biological parameters.
    Gao RJ, Bao HZ, Yang Q, Cong Q, Song JN, Wang L.
    Breast Cancer Res Treat; 2005 Sep 15; 93(2):111-5. PubMed ID: 16187230
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 15; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
    Pich A, Margaria E, Chiusa L.
    J Clin Oncol; 2000 Aug 15; 18(16):2948-56. PubMed ID: 10944127
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.